ロード中...
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
Cerebrospinal fluid and positron emission tomography biomarkers accurately predict an underlying Alzheimer's disease (AD) pathology; however, they represent either invasive or expensive diagnostic tools. Therefore, a blood-based biomarker like plasma amyloid beta (Aβ) that could correlate with...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3706955/ https://ncbi.nlm.nih.gov/pubmed/23470128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt162 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|